United States Diabetes Devices Market Share

Statistics for the 2023 & 2024 United States Diabetes Devices market share, created by Mordor Intelligence™ Industry Reports. United States Diabetes Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of United States Diabetes Devices Industry

The United States diabetes care devices market is semi-consolidated, with few significant and generic players. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead on its way in the race to create an artificial pancreas system, rather than merely offering a boost to the continuous glucose monitoring devices market. There have been constant innovations driven by manufacturers such as Abbott and Medtronic, while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.

US Diabetes Devices Market Leaders

  1. Abbott

  2. Dexcom

  3. Becton Dickinson

  4. Medtronic

  5. F. Hoffmann-La Roche AG

*Disclaimer: Major Players sorted in no particular order

United States Diabetes Devices Market Concentration

US Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)